Active Research Protocols
- 06-C-0150 – A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia
- 12-C-0170 – A Phase 1B Study to Evaluate the Safety and Induction of Immune Response of CRS 207 in Combination with Pemetrexed and Cisplatin as Front-Line Therapy in Adults with Malignant Pleural Mesothelioma
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014